- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Expulsion rates of levonorgestrel IUD same among women with heavy menstrual flow versus contraception users: Study
Brazil: A recent study in the journal Contraception suggests placing the 52 mg levonorgestrel (LNG) 52 mg intrauterine system (IUS) following the cesation of bleeding or a reduction of menstrual flow among women having heavy menstrual bleeding. This is because the strategy was related to similar expulsion risk compared to users for contraception.
Abnormal uterine bleeding is the most common ground for women seeking gynecologic care during reproductive age, and can be related to many gynecologic diseases. Women who consult for abnormal uterine bleeding who do not desire more children have been treated with procedure such as endometrial ablation, hysterectomy, and uterine artery embolization. These procedures are limited by their expensive cost and morbidity and mortality associated with its use.
LNG 52 mg IUS was introduced as a successful treatment for heavy menstrual bleeding in recent decades. In 2015, this device was approved by the US FDA as a contraceptive method and as a medical treatment for heavy menstrual bleeding. One of the concerns related to its use is the possibility of expulsion, which certainly impairs the efficacy of treatment.
Against the above background, Ilza Monteiro, University of Campinas Faculty of Medical Sciences (UNICAMP), Campinas, São Paulo, Brazil, and colleagues conducted the study with an objective of comparing the expulsion rates of LNG 52 mg IUS in wiomne with heavy menstrual bleeding compared to women using solely for contraception.
For this purpose, the researchers conducted an audit study of 548 (8.8%) women with heavy menstrual bleeding and 5655 (91.2%) users for contraception (comparison group) for 4 years in Campinas, Brazil. They retrieved expulsion rates, sociodemographic data, and variables associated to device placement. In women with heavy menstrual bleeding, the device was placed after the cesstion of bleeding or after the reduction of menstrual flow.
Following were the study's key findings:
· Thirty-one of 548 (5.6%) women with heavy menstrual bleeding and 315 of 5655 (5.6%) from the comparison group expelled the device.
· This constituted 7.8 expulsions/100 women-years in women with heavy menstrual bleeding and 10.3 expulsions/100 women-years from the comparison group.
· Expulsion risk was associated with previous cesarean delivery in both groups (OR 1.93).
"Expulsion rates of the LNG IUS among women with heavy menstrual bleeding whose IUS was placed after the cessation or reduction of bleeding were same to expulsion rates among users for contraception," wrote the authors. "Previous cesarean delivery was a risk factor for expulsion."
Reference:
The study titled, "Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception," was published in the journal Contraception.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751